…endent cytotoxicity. However, the non-cytotoxic role of GZMK in lung adenocarcinoma (LUAD) remains largely elusive.Methods Multiomics datasets were integr…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 237 of 2459…%) patients with NT-proBNP >2000 ng/L and 51 (8%) patients with NT-proBNP 400–2000 ng/L received an echocardiogram within the recommended…
… sclerosis (MS), neuromyelitis optica spectrum disease (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and autoimmune glial fibrillary acidic protein astrocyt…
…ents and those treated with standard neoadjuvant HER2 therapies paclitaxel, with or without carboplatin, trastuzumab and pertuzumab (Taxol…
…624 (95% CI 504 to 743) mls, respectively.Discussion Unmeasured silicosis may partially explain some of the observed effect of previous T…
…t, only sRAGE demonstrated an association with the diagnosis of PARDS and ICU mortality, which remained after controlling for confoun…
…ntly associated with lower incidence of hypertension, diabetes, coronary heart disease, stroke and ED (all p trend <0.05). Compared with participants …
…and metabolic abnormalities, including dyslipidaemia leading to cardiovascular disease.Methods This systematic review followed the Preferred Reporting…
…, a selective IL-23 inhibitor, was administered at the standard psoriasis regimen. Over 12 months, the patient achieved clinical, endosco…
…eliorate metabolic derangement and cardiac dysfunction in dbCM. Diltiazem, a calcium channel blocker, reduces cardiac calcium overload an…
…Fumarate derivatives are FDA-approved molecules used to treat autoimmune diseases by activating the nuclear factor erythroid 2-related factor 2 (…
…sity, GORD and deconditioning, may be perceived as arising from asthma. The first priority should always be to confirm if asthma is th…